Michael M. Page

2.3k total citations
42 papers, 1.7k citations indexed

About

Michael M. Page is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael M. Page has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael M. Page's work include Lipoproteins and Cardiovascular Health (18 papers), Heart Rate Variability and Autonomic Control (7 papers) and Pharmaceutical Economics and Policy (6 papers). Michael M. Page is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Heart Rate Variability and Autonomic Control (7 papers) and Pharmaceutical Economics and Policy (6 papers). Michael M. Page collaborates with scholars based in Australia, United Kingdom and New Zealand. Michael M. Page's co-authors include Peter Watkins, Gerald F. Watts, J Mackay, A. C. Asmal, Christopher R.W. Edwards, Ann Rumley, Brian R. Walker, Michael Marmot, Philip Clarke and Sylvia Checkley and has published in prestigious journals such as The Lancet, Circulation and Diabetes Care.

In The Last Decade

Michael M. Page

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael M. Page Australia 16 733 591 449 326 153 42 1.7k
Birgitta Linde Sweden 23 479 0.7× 435 0.7× 554 1.2× 427 1.3× 231 1.5× 56 1.7k
René R. Wenzel Germany 25 1.3k 1.7× 353 0.6× 214 0.5× 646 2.0× 60 0.4× 66 2.1k
Lia E. Bang Denmark 23 1.3k 1.7× 498 0.8× 385 0.9× 158 0.5× 51 0.3× 88 2.1k
R. J. M. Corrall United Kingdom 22 810 1.1× 630 1.1× 524 1.2× 441 1.4× 278 1.8× 77 2.2k
Eleanor Scott United Kingdom 26 652 0.9× 584 1.0× 819 1.8× 538 1.7× 334 2.2× 71 2.5k
Maurı́cio Wajngarten Brazil 23 731 1.0× 175 0.3× 251 0.6× 189 0.6× 130 0.8× 100 1.7k
Christine Darwin United States 21 386 0.5× 551 0.9× 871 1.9× 234 0.7× 365 2.4× 36 1.8k
Takuo Hirose Japan 30 1.6k 2.2× 406 0.7× 573 1.3× 192 0.6× 56 0.4× 135 2.7k
Bengt Rundqvist Sweden 27 1.7k 2.3× 569 1.0× 163 0.4× 247 0.8× 34 0.2× 51 2.5k
Gregory Kline Canada 29 264 0.4× 1.1k 1.9× 1.2k 2.8× 282 0.9× 55 0.4× 142 2.4k

Countries citing papers authored by Michael M. Page

Since Specialization
Citations

This map shows the geographic impact of Michael M. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Page more than expected).

Fields of papers citing papers by Michael M. Page

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Page. The network helps show where Michael M. Page may publish in the future.

Co-authorship network of co-authors of Michael M. Page

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Page. A scholar is included among the top collaborators of Michael M. Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Page. Michael M. Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Michael M., Winita Hardikar, George Alex, et al.. (2023). Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand. Atherosclerosis. 387. 117305–117305. 8 indexed citations
2.
Page, Michael M., Katrina L. Ellis, Dick C. Chan, et al.. (2022). A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia. Journal of clinical lipidology. 16(4). 525–529. 3 indexed citations
3.
Siru, Ranita, et al.. (2021). Abnormal Laboratory Results: Approach to the diagnosis of secondary hypertension in adults. Australian Prescriber. 44(5). 165–169. 3 indexed citations
4.
Siru, Ranita, et al.. (2020). Risk of undetected cases of gestational diabetes mellitus during the COVID‐19 pandemic. The Medical Journal of Australia. 213(7). 335–335. 8 indexed citations
5.
Page, Michael M., Katrina L. Ellis, Jing Pang, et al.. (2020). Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia. Clinica Chimica Acta. 510. 211–215. 11 indexed citations
6.
Page, Michael M., Elif I. Ekinci, John R. Burnett, et al.. (2020). Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand. Journal of Clinical Apheresis. 36(1). 48–58. 7 indexed citations
7.
Page, Michael M., Damon A. Bell, & Gerald F. Watts. (2019). Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?. Clinical Genetics. 97(4). 543–555. 6 indexed citations
8.
Rawlins, Matthew, et al.. (2019). Pharmacokinetics of flucloxacillin during prolonged intermittent renal replacement therapy in a 76-year-old man. Journal of Chemotherapy. 31(7-8). 419–423. 2 indexed citations
9.
Ward, Natalie C., Michael M. Page, & Gerald F. Watts. (2019). Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies. Diabetes Obesity and Metabolism. 21(S1). 52–62. 2 indexed citations
10.
Rawlins, Matthew, John R. Dyer, Chris Allen, et al.. (2019). Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy. Chemotherapy. 64(1). 17–21. 7 indexed citations
11.
Page, Michael M., Amanda J. Hooper, Paul Glendenning, & John R. Burnett. (2017). Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinic. BMJ Case Reports. 2017. bcr–2016. 1 indexed citations
12.
Page, Michael M., et al.. (2016). Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country. Journal of clinical lipidology. 10(5). 1188–1194. 11 indexed citations
13.
Page, Michael M. & Gerald F. Watts. (2015). Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacology. Expert Opinion on Drug Metabolism & Toxicology. 11(9). 1505–1515. 8 indexed citations
14.
Page, Michael M. & Gerald F. Watts. (2015). Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention. Expert Opinion on Emerging Drugs. 20(2). 299–312. 6 indexed citations
15.
Page, Michael M., Damon A. Bell, Amanda J. Hooper, Gerald F. Watts, & John R. Burnett. (2013). Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children. Best Practice & Research Clinical Endocrinology & Metabolism. 28(3). 387–403. 29 indexed citations
16.
Page, Michael M., Frank Sanfilippo, Elizabeth Geelhoed, Tom Briffa, & Michael Hobbs. (2012). Earlier translation of evidence into public subsidy may prevent morbidity and mortality: an example using statins in diabetics with normal cholesterol levels. Australian and New Zealand Journal of Public Health. 36(5). 435–440. 1 indexed citations
17.
Brunner, Eric J., Harry Hemingway, Brian R. Walker, et al.. (2002). Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome. Circulation. 106(21). 2659–2665. 420 indexed citations
18.
Page, Michael M., et al.. (1981). Atypical case of alcohol-induced Cushingoid syndrome.. BMJ. 282(6270). 1117–1118. 14 indexed citations
19.
Page, Michael M., Robert Smith, & Peter Watkins. (1976). Cardiovascular effects of insulin.. BMJ. 1(6007). 430–432. 51 indexed citations
20.
Page, Michael M., K. G. M. M. Alberti, Richard Greenwood, et al.. (1974). Treatment of Diabetic Coma with Continuous Low-dose Infusion of Insulin. BMJ. 2(5921). 687–690. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgitta Linde Breakdown of academic impact, for papers by René R. Wenzel Breakdown of academic impact, for papers by Lia E. Bang Breakdown of academic impact, for papers by R. J. M. Corrall Breakdown of academic impact, for papers by Eleanor Scott Breakdown of academic impact, for papers by Maurı́cio Wajngarten Breakdown of academic impact, for papers by Christine Darwin Breakdown of academic impact, for papers by Takuo Hirose Breakdown of academic impact, for papers by Bengt Rundqvist Breakdown of academic impact, for papers by Gregory Kline
Rankless by CCL
2026